Evidence map›Paper›PMID 36686913›Full record

ArticleRSC advances2023

Synthesis, characterization, and

Humaira Yasmeen Gondal, Sobia Tariq, Shahzaib Akhter, Abdul Rauf Raza, Muhammad Fayyaz Ur Rehman, Syeda Laila Rubab

Open access · goldAbstract read
In one paragraph

Article in RSC advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Bisindole Compounds-Synthesis and Medicinal Properties.Antibiotics (Basel, Switzerland) · 2024
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Humaira Yasmeen GondalInstitute of Chemistry, Ibn e Sina Block, University of Sargodha Sargodha-40100 Pakistan rauf.raza@uos.edu.pk humaira.yasmeen@uos.edu.pk sobiatariq66@gmail.com shahzaibakhter740@gmail.com muhammad.fayyaz@uos.edu.pk +92-48-9230-546.
Sobia TariqInstitute of Chemistry, Ibn e Sina Block, University of Sargodha Sargodha-40100 Pakistan rauf.raza@uos.edu.pk humaira.yasmeen@uos.edu.pk sobiatariq66@gmail.com shahzaibakhter740@gmail.com muhammad.fayyaz@uos.edu.pk +92-48-9230-546.
Shahzaib AkhterInstitute of Chemistry, Ibn e Sina Block, University of Sargodha Sargodha-40100 Pakistan rauf.raza@uos.edu.pk humaira.yasmeen@uos.edu.pk sobiatariq66@gmail.com shahzaibakhter740@gmail.com muhammad.fayyaz@uos.edu.pk +92-48-9230-546.ORCID https://orcid.org/0000-0002-8622-2549
Abdul Rauf RazaInstitute of Chemistry, Ibn e Sina Block, University of Sargodha Sargodha-40100 Pakistan rauf.raza@uos.edu.pk humaira.yasmeen@uos.edu.pk sobiatariq66@gmail.com shahzaibakhter740@gmail.com muhammad.fayyaz@uos.edu.pk +92-48-9230-546.
Muhammad Fayyaz Ur RehmanInstitute of Chemistry, Ibn e Sina Block, University of Sargodha Sargodha-40100 Pakistan rauf.raza@uos.edu.pk humaira.yasmeen@uos.edu.pk sobiatariq66@gmail.com shahzaibakhter740@gmail.com muhammad.fayyaz@uos.edu.pk +92-48-9230-546.ORCID https://orcid.org/0000-0003-2901-7212
Syeda Laila RubabDepartment of Chemistry, Division of Science and Technology, University of Education Lahore-54770 Pakistan laila.rubab@ue.edu.pk.
University of Sargodha · PKUniversity of Okara · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present study involved the targeted synthesis and characterization of novel indole amines with anti-acetylcholinesterase profiling. A series of proposed indole amines was virtually screened against human acetylcholinesterase. A few indole amines (23, 24, and 25) showing strong enzyme binding in the

Identifiers

PMID36686913
PMCPMC9811652
OpenAlexW4313592693

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.